In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess.
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 2004 May; 89(5):2024-7.